Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)

Cancer

Volumn 101, Issue 2, 2004, Pages 385-394

  Pillon, Marta ^a   Di Tullio, Maria Teresa ^b   Garaventa, Alberto ^c   Cesaro, Simone ^a   Putti, Maria Caterina ^a   Favre, Claudio ^d   Lippi, Alma ^e   Surico, Gianmarco ^f   Di Cataldo, Andrea ^g   D'Amore, Emanuele ^h   Zanesco, Lulgi ^a   Rosolen, Angelo ^a,i  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h SAN BORTOLO HOSPITAL   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

B cell NHL; Burkitt lymphoma; Child; Non Hodgkin lymphoma; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE; VINDESINE;

ARACHNOIDITIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; BLOOD TOXICITY; BURKITT LYMPHOMA; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; DEATH; DRUG MEGADOSE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION; ITALY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SECOND CANCER; SECOND LOOK SURGERY; SEIZURE; STATISTICAL ANALYSIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LYMPHOMA, B-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3042703949     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20382     Document Type: Article

References (20)

1. Anderson JR, Wilson JF, Jenkin DT, et al. Childhood non-Hodgkin's lymphoma. Results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 1983;308:559-565.
2. Anderson JR, Jenkin RD, Wilson IF, et al. Long-term follow-up of patients treated with COMP or LSA2-L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Study Group. J Clin Oncol. 1993;11:1024-1032.
3. Finlay JL, Anderson JR, Cecalupo AJ, et al. Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552. Med Pediatr Oncol. 1994;23:453-463.
4. Cairo MS, Krailo MD, Morse M, et al. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ("Orange") in children with advanced nonlyphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group report. Leukemia. 2002;16:594-600.
5. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol. 1991;9:123-132.
6. Patte C, Leverger G, Perel Y, et al. Updated results of the LMB86 protocol of the French Pediatric Oncology Society (SFOP) for B-cell non-Hodgkin's lymphomas (B-NHL) with CNS involvement (CNS+) and B-ALL. Med Pediatr Oncol. 1990;18:397.
7. Patte C, Auperin A, Michon J, et al. The Société Francaise d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370-3379.
8. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence. Results of a treatment stratified for biologic subtypes and stage. A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol. 1995;13:359-372.
9. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group trial NHL BFM 90. Blood. 1999;10:3294-3306.
10. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-339.
11. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet. 1988;1:292-293.
12. Bennet JM, Catovsky D, Daniel MT, et al. Proposal for the classification of the acute leukemias. French-American-British (FAB) Co-operative Group. Br J Haematol. 1976;33:451-458.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-481.
14. Peto R, Peto J. Asymptotically efficient rank invariant test procedurtes. J R Stat Soc A. 1972;135:185-198.
15. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
16. Brecher ML, Schwenn MR, Coppes MJ, et al. Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with Stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol. 1997;29:526-533.
17. Adde M, Shad A, Venzon D, et al. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol. 1998;25:33-39.
18. Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925-934.
19. Meadows AT, Sposto R, Jenkin RD, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Children's Cancer Study Group. J Clin Oncol. 1989;7:92-99.
20. Atra A, Imeson JD, Hobson R, et al. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. Br J Cancer. 2000;82:1396-1402.